stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Tenaya Therapeutics, Inc.

United States Β· NASDAQ:Β TNYA Β· Market cap: Β· P/E: Β· P/S:

Tenaya Therapeutics is a biotech company developing gene therapies and small-molecule drugs to treat heart disease.

Tenaya Therapeutics is a small biotech company trying to solve a big, stubborn problem: heart disease, the leading cause of death worldwide. Most heart drugs today manage symptoms β€” they lower blood pressure or reduce cholesterol β€” but they don't repair a heart that is already failing. Tenaya is betting that the next wave of heart medicine will come from fixing the disease at its root, by replacing broken genes or correcting the biology inside heart cells.

The company works on two kinds of treatment. One is gene therapy: delivering a working copy of a gene into heart cells so the heart can function properly again. The other is small-molecule drugs β€” conventional pills β€” that target the underlying biology of heart muscle disease. Its lead gene therapy program targets a genetic form of heart failure, and it is also developing treatments for a broader condition where the heart muscle becomes enlarged and weak. Like most clinical-stage biotechs, Tenaya does not sell anything yet. It has no revenue from products and funds its work through cash reserves, partnerships, and the public markets β€” it listed on NASDAQ in 2021. Investors are essentially paying for a pipeline of experiments, and the share price swings on trial data, regulatory news, and how long the company's cash can last. The real payoff would come if a therapy wins approval and gets sold to hospitals and patients, or if a larger drugmaker licenses or buys the program.


That makes Tenaya a high-risk, high-reward story. Gene therapy for the heart is technically hard β€” you have to get the treatment into the right cells and keep the immune system from rejecting it β€” and competitors like Novartis and other gene-therapy players are chasing similar ground. Tenaya's edge, if it has one, is focus: a small team aimed squarely at the heart, where the unmet need is enormous and effective treatments are still scarce.

Saved answer Β· last researched 16 Nov 2026